2,5-Dimethoxyphenylpiperidines作为选择性色素5-HT2A受体对抗剂的发现和结构-活性关系
Emil M Ro Rsted1,2, Anders A Jensen1,2, Gints Smits3
1Lophora, Charlottenlund, Copenhagen 2920, Denmark.
研究人员发现了一种新型的选择性血清素2A受体 (5-HT2AR) 激动剂,即2,5-dimethoxyphenylpiperidines. 化合物LPH-5显示出作为治疗精神疾病治疗剂的潜力.
科学领域:
- 神经科学是一个神经科学.
- 心理药理学 心理药理学
- 药用化学 医学化学
背景情况:
- 经典的迷幻药物 (psilocybin,LSD,DMT) 显示出对精神疾病的治疗承诺.
- 它们的急性作用与血清素2A受体 (5-HT2AR) 激动性有关,但持久的治疗作用尚不清楚.
- 需要新的化合物来选择性地准5-HT2AR以获得治疗效益.
研究的目的:
- 发现新的选择性血清素2A受体 (5-HT2AR) 激动剂.
- 为了研究一个新的化学类的结构-活性关系 (SAR).
- 为了识别具有可取药物特性的化合物.
主要方法:
- 2,5-dimethoxyphenylpiperidine类似物的设计和合成.
- 药理学评估受体结合和功能活动.
- 结构-活动关系分析以优化选择性和属性.
主要成果:
- 发现2,5-dimethoxyphenylpiperidines作为一种新型的选择性5-HT2AR激动剂.
- 鉴定LPH-5[(S) -11]作为一种强效和选择性的5-HT2AR激动剂.
- LPH-5表现出有利的类似药物的特性.
结论:
- 2,5-dimethoxyphenylpiperidines代表了对5-HT2AR向治疗的有希望的新支架.
- LPH-5是进一步开发精神病学适应症的潜在候选者.
- 选择性5-HT2AR调制可能提供超出急性迷幻效应的治疗益处.
更多相关视频
14:21Creating Dynamic Images of Short-lived Dopamine Fluctuations with lp-ntPET: Dopamine Movies of Cigarette Smoking
Published on: August 6, 2013
07:16Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
相关概念视频
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Antipsychotic Drugs: Typical and Atypical Agents
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
The direct-acting...
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
